Task A09: In vitro screening for antibacterial activity against public health disease pathogens

任务 A09：体外筛选针对公共卫生疾病病原体的抗菌活性

• 批准号: 10168801
• 负责人: THOMAS PATTERSON
• 金额: $ 9.93万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-05-18 至 2021-05-17
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10168801
• 关键词: Acinetobacter; Advanced Development; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Resistance; Bacteria; Biological Assay; Contracts; Development; Disease; Enterobacter; Enterococcus; Escherichia coli; In Vitro; Klebsiella; Maintenance; Mycotoxins; Proteus; Pseudomonas aeruginosa; Public Health; Staphylococcus aureus; Stenotrophomonas; Streptococcus; Toxin; combat; fungus; in vitro testing; pathogen; screening; therapeutic development

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

该合同提供潜在抗菌和抗真菌剂的体外测试、对抗细菌和真菌产生的毒素影响的功效、细菌、真菌和毒素库存的维护以及相关测定的开发。